E. Schifferdecker

494 total citations
29 papers, 375 citations indexed

About

E. Schifferdecker is a scholar working on Endocrinology, Diabetes and Metabolism, Genetics and Immunology. According to data from OpenAlex, E. Schifferdecker has authored 29 papers receiving a total of 375 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Endocrinology, Diabetes and Metabolism, 8 papers in Genetics and 8 papers in Immunology. Recurrent topics in E. Schifferdecker's work include Diabetes and associated disorders (8 papers), T-cell and B-cell Immunology (6 papers) and Diabetes Management and Research (4 papers). E. Schifferdecker is often cited by papers focused on Diabetes and associated disorders (8 papers), T-cell and B-cell Immunology (6 papers) and Diabetes Management and Research (4 papers). E. Schifferdecker collaborates with scholars based in Germany. E. Schifferdecker's co-authors include E. Fr�mter, Κ. Schöffling, H. Schatz, Hellmuth Freyberger, B. O. Boehm, Klaus D. Schmidt, Bernhard O. Boehm, Michael Derwahl, H Schatz and Halil İbrahim Yakut and has published in prestigious journals such as Pflügers Archiv - European Journal of Physiology, European Journal of Endocrinology and Journal of Molecular Medicine.

In The Last Decade

E. Schifferdecker

27 papers receiving 364 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E. Schifferdecker Germany 10 127 99 80 72 53 29 375
Aditi Gupta India 9 53 0.4× 47 0.5× 108 1.4× 64 0.9× 82 1.5× 20 350
Nicola Locuratolo Italy 12 123 1.0× 27 0.3× 24 0.3× 134 1.9× 33 0.6× 22 506
C. Thivolet France 14 486 3.8× 306 3.1× 74 0.9× 81 1.1× 39 0.7× 28 839
Sophia M. Chung United States 15 58 0.5× 24 0.2× 172 2.1× 63 0.9× 69 1.3× 34 548
Rieko Kominami Japan 12 162 1.3× 35 0.4× 26 0.3× 131 1.8× 19 0.4× 24 404
W. Bruce Wilson United States 14 54 0.4× 30 0.3× 127 1.6× 158 2.2× 87 1.6× 27 553
Bo Young Chun South Korea 12 49 0.4× 21 0.2× 115 1.4× 96 1.3× 52 1.0× 41 376
Giavonni Lewis United States 10 24 0.2× 28 0.3× 41 0.5× 71 1.0× 79 1.5× 29 420
Sarper Karaküçük Türkiye 17 22 0.2× 63 0.6× 352 4.4× 75 1.0× 63 1.2× 42 674

Countries citing papers authored by E. Schifferdecker

Since Specialization
Citations

This map shows the geographic impact of E. Schifferdecker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Schifferdecker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Schifferdecker more than expected).

Fields of papers citing papers by E. Schifferdecker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Schifferdecker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Schifferdecker. The network helps show where E. Schifferdecker may publish in the future.

Co-authorship network of co-authors of E. Schifferdecker

This figure shows the co-authorship network connecting the top 25 collaborators of E. Schifferdecker. A scholar is included among the top collaborators of E. Schifferdecker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Schifferdecker. E. Schifferdecker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Radtke, H. W., et al.. (2015). Early Changes of Plasma Lipid Status and Glucose Tolerance during the Course of Chronic Renal Failure. Contributions to nephrology. 41. 332–336.
2.
Schifferdecker, E., Steffen Hering, Bernhard Böhm, et al.. (2009). Thyroid Hormone Binding Inhibition in Critically ill Patients – Who is the Inhibitor?. Experimental and Clinical Endocrinology & Diabetes. 95(2). 267–270. 2 indexed citations
3.
Schmidt, Klaus D., Bernhard O. Boehm, E. Schifferdecker, & K. H. Usadel. (2009). Long-term adherence to intensified conventional insulin therapy. Experimental and Clinical Endocrinology & Diabetes. 103(4). 256–259. 1 indexed citations
4.
Freyberger, Hellmuth, et al.. (2000). Increased levels of platelet-derived growth factor in vitreous fluid of patients with proliferative diabetic retinopathy. Experimental and Clinical Endocrinology & Diabetes. 108(2). 106–109. 69 indexed citations
5.
Pfeiffer, Andreas, Matthias Möhlig, Michael Ristow, et al.. (1997). Circulating Tumor Necrosis Factor α is Elevated in Male but Not in Female Patients With Type II Diabetes Mellitus. Hormone and Metabolic Research. 29(3). 111–114. 54 indexed citations
6.
Schifferdecker, E., Klaus D. Schmidt, B. O. Boehm, & H. Schatz. (1994). Long-term compliance of intensified insulin therapy. Diabetes Research and Clinical Practice. 23(1). 17–23. 31 indexed citations
7.
Freyberger, Hellmuth, et al.. (1994). [Regression of hard exudates in diabetic background retinopathy in therapy with etofibrate antilipemic agent].. PubMed. 89(11). 594–7, 633. 16 indexed citations
8.
Boehm, Bernhard O., et al.. (1993). HLA-DR3 and HLA-DR5 confer risk for autoantibody positivity against the thyroperoxidase (mic-TPO) antigen in healthy blood donors. Journal of Molecular Medicine. 71(3). 221–5. 19 indexed citations
9.
Boehm, B. O., P. K�hnl, Burkhard Manfras, et al.. (1992). HLA-DRB3 gene alleles in Caucasian patients with Graves' disease. Journal of Molecular Medicine. 70(10). 956–60. 36 indexed citations
10.
Schifferdecker, E., P. Kühnl, Κ. Schöffling, et al.. (1991). Immunogenetic markers in patients with Graves' disease. Journal of Molecular Medicine. 69(6). 256–260. 14 indexed citations
11.
Schifferdecker, E., et al.. (1991). HLA-DR3 and variations of the T cell receptor β gene in Graves' disease. European Journal of Endocrinology. 124(6). 658–660. 2 indexed citations
13.
Boehm, Bernhard O., E. Schifferdecker, P. Kuehnl, & Κ. Schöffling. (1988). Linkage of HLA-DRβ specific restriction fragment length polymorphisms with Graves' disease. European Journal of Endocrinology. 119(2). 251–256. 9 indexed citations
14.
Schifferdecker, E., Steffen Hering, H. Förster, et al.. (1988). Freie Fettsäuren im Serum bei krisenhaften Erkrankungen: Spielen sie eine Rolle bei der Proteinbindung von Schilddrüsenhormonen?. Journal of Molecular Medicine. 66(7). 308–313. 2 indexed citations
16.
Schifferdecker, E., et al.. (1986). [Anorexia nervosa--endocrine changes].. PubMed. 81(24). 795–803. 2 indexed citations
17.
Schifferdecker, E., F. Schulz, & Κ. Schöffling. (1986). Die Bestimmung von TSH-Rezeptor-Antikörpern — Klinische Wertigkeit. Journal of Molecular Medicine. 64(1). 8–14. 2 indexed citations
18.
Schifferdecker, E., F. Schulz, & Κ. Schöffling. (1985). Value of TRAK, a TSH receptor autoantibody test kit, in the diagnosis and treatment of Graves' disease. European Journal of Endocrinology. 110(1_Suppla). S67–S68. 1 indexed citations
19.
Schifferdecker, E. & E. Fr�mter. (1978). The AC impedance of necturus gallbladder epithelium. Pflügers Archiv - European Journal of Physiology. 377(2). 125–133. 41 indexed citations
20.
Schifferdecker, E.. (1977). Messungen der elektrischen Impedanz am Epithel der Gallenblase von Necturus maculosus. Medical Entomology and Zoology. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026